SMTL ID : 5oc8.1

HDM2 (17-111, WILD TYPE) COMPLEXED WITH NVP-HDM201 AT 1.56A

Coordinates
PDB Format
Method
X-RAY DIFFRACTION 1.56 Å
Oligo State
monomer
Ligands
1 x 9QW: (4~{S})-5-(5-chloranyl-1-methyl-2-oxidanylidene-pyridin-3-yl)-4-(4-chlorophenyl)-2-(2,4-dimethoxypyrimidin-5-yl)-3-propan-2-yl-4~{H}-pyrrolo[3,4-d]imidazol-6-one(Non-covalent)
1 x CL: CHLORIDE ION(Non-functional Binders)
Links
RCSB   PDBe   PDBj   PDBsum   CATH   PLIP
Citation
Jeay, S. et al., Dose and Schedule Determine Distinct Molecular Mechanisms Underlying the Efficacy of the p53-MDM2 Inhibitor HDM201. Cancer Res. (2018)
Release Date
2018-08-22
Peptides
E3 ubiquitin-protein ligase Mdm2: A
SMTL:PDB
SMTL Chain Id:
PDB Chain Id:
A
A

E3 ubiquitin-protein ligase Mdm2

Related Entries With Identical Sequence

1t4e.1 | 3jzk.1 | 4ere.1 | 4ere.2 | 4erf.1 | 4erf.2 | 4erf.3 | 4oas.1 | 4oas.2 | 4oas.3 | 4oba.1 | 4oba.2 | 4oba.3 | 4occ.1 | 4occ.2 | 4occ.3 | 4qo4.1 | 4qoc.1 | 4qoc.2 | 4qoc.3 | 4qoc.4 | 4qoc.5 | 4qoc.6 | 4zyf.1 | 4zyi.1 | 5ln2.1 | 6ggn.1 | 6i29.1 | 6q96.1 | 6q96.2  more...